Surface-dependent modulation of proliferation, bone matrix molecules, and inflammatory factors in human osteoblasts

Journal of Biomedical Materials Research - Part A

Volumn 89, Issue 3, 2009, Pages 687-696

  Tonnarelli, Beatrice ^a   Manferdini, Cristina ^a   Piacentini, Anna ^a   Codeluppi, Katia ^a   Zini, Nicoletta ^b   Ghisu, Sonia ^c   Facchini, Andrea ^a,d   Lisignoli, Gina ^a  

^a Ist Ric Codivilla Putti I O R   (Italy)

^b CNR   (Italy)

^c Laboratorio di Biologia Cellulare e Microscopia Elettronica   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Bone matrix; Chemokines; Osteoblasts; Surface properties

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL PROPERTIES; BONE FORMATION; BONE MATRIX; CHEMOKINES; COLLAGEN TYPE I; CYTOKINES; EXTRACELLULAR MATRICES; GROWTH FACTOR; HAEMATOPOIESIS; HAEMATOPOIETIC SYSTEMS; HUMAN OSTEOBLAST; HUMAN OSTEOBLAST PROLIFERATION; HYALURONAN; MICROENVIRONMENT; MRNA EXPRESSION; OSTEOBLAST PROLIFERATION; OSTEOCALCIN; OSTEOPONTIN; PLASTIC SUBSTRATES; PROTEIN LEVEL;

BIOLOGICAL MATERIALS; CALCIUM; CALCIUM PHOSPHATE; CELL CULTURE; ENZYME ACTIVITY; HYDROXYLATION; MODULATION; OSTEOBLASTS; PEPTIDES; PLASTICS; SCAFFOLDS; SURFACE PROPERTIES; TRACE ANALYSIS;

BONE;

ALKALINE PHOSPHATASE; CALCIUM PHOSPHATE; CHEMOKINE; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; CHEMOKINE RECEPTOR CXCR5; COLLAGEN TYPE 1; CXCL13 CHEMOKINE; HYALURONIC ACID; MATRIX PROTEIN; MESSENGER RNA; OSTEOCALCIN; OSTEONECTIN; OSTEOPONTIN; PLASTIC; STROMAL CELL DERIVED FACTOR 1; TISSUE SCAFFOLD;

ARTICLE; BONE MATRIX; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMPLANT; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SURFACE PROPERTY;

AGED; BONE MATRIX; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINES; DURAPATITE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; OSTEOBLASTS; PLASTICS; RECEPTORS, CHEMOKINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURFACE PROPERTIES; TISSUE SCAFFOLDS;

EID: 66249085569     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32019     Document Type: Article

References (50)

1. Rodan GA. Coupling of bone resorption and formation during bone remodeling. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. San Diego: Academic Press; 2001. p 290-301.
2. Eriksen EF. Normal and pathological remodeling of human trabecular bone: Three dimensional reconstruction of the remodeling sequence in normals and metabolic bone disease. Endocr Rev 1986;7:379-108.
3. Martin TJ, Sims NA. Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol Med 2005; 11:76-81.
4. Ducy P, Schinke T, Karsenty G. The osteoblast: A sophisticated fibroblast under central surveillance. Science 2000;289: 1501-1504.
5. Xing L, Schwarz EM, Boyce BF. Osteoclast precursors. RANKL/RANK, and immunology. Immunol Rev 2005;208: 19-29.
6. Fernandez-Tresguerres-Hernandez-Gil I, Alobera-Gracia MA, Bianco-Jerez L, del-Canto-Pingarron M, Bianco-Jerez L. Physiological bases of bone regeneration I. Histology and physiology of bone tissue. Med Oral Patol Oral Cir Bucal 2006;11: E47-E51.
7. Horowitz M. Matrix proteins versus cytokines in the regulation of osteoblast function and bone formation. Calcif Tissue Int 2003;72:5-7.
8. Balooch G, Balooch M, Nalla RK, Schilling S, Filvaroff EH, Marshall GW, Marshall SJ, Ritchie RO, Derynck R, Alliston T. TGF-β regulates the mechanical properties and composition of bone matrix. Proc Natl Acad Sci USA 2005;102:18813- 18818.
9. Yang X, Tare RS, Partridge KA, Roach HI, Clarke NM, How- die SM, Shakesheff KM, Oreffo RO. Induction of human osteoprogenitor chemotaxis, proliferation, differentiation, and bone formation by osteoblast stimulating factor-1/pleiotro- phin: Osteoconductive biomimetic scaffolds for tissue engineering. J Bone Miner Res 2003;18:47-57.
10. Semerad CL, Christopher MJ, Liu F, Short B, Simmons PJ, Winkler I, Levesque JP, Chappel J, Ross FP, Link DC. G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood 2005;106:3020-3027.
11. Honczarenko M, Ratajczak MZ, Nicholson-Weller A, Silber- stein LE. Complement C3a enhances CXCL12 (SDF-l)-medi- ated chemotaxis of bone marrow hematopoietic cells independently of C3a receptor. J Immunol 2005;175:3698-3706.
12. Yano S, Mentaverri R, Kanuparthi D, Bandyopadhyay S, Rivera A, Brown EM, Chattopadhyay N. Functional expression of beta-chemokine receptors in osteoblasts: Role of regulated upon activation, normal T cell expressed and secreted (RANTES) in osteoblasts and regulation of its secretion by osteoblasts and osteoclasts. Endocrinology 2005;146:2324- 2335.
13. Baggiolini M. Chemokines in pathology and medicine. J Intern Med 2001;250:91-104.
14. Szekanecz Z, Kim J, Koch AE. Chemokines and chemokine receptors in rheumatoid arthritis. Semin Immunol 2003;15:15- 21.
15. Zlotnik A, Yoshie O. Chemokines: A new classification system and their role in immunity. Immunity 2000;12:121-127.
16. Lapidot T, Petit I. Current understanding of stem cell mobilization: The roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 2002;30:973-981.
17. Lisignoli G, Toneguzzi S, Piacentini A, Cristino S, Grassi F, Cavallo C, Facchini A. CXCL12 (SDF-1) and CXCL13 (BCA-1) chemokines significantly induce proliferation and collagen type I expression in osteoblasts from osteoarthritis patients. J Cell Physiol 2006;206:78-85.
18. Honczarenko M, Le Y, Swierkowski M, Ghiran I, Glodek AM, Silberstein LE. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 2006;24:1030-1041.
19. Wang J, Loberg R, Taichman RS. The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis. Cancer Metastasis Rev 2006;25:573-587.
20. Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, Yoshida N, Kikutani H, Kishimoto T. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996; 382:635-638.
21. Grassi F, Cristino S, Toneguzzi S, Piacentini A, Facchini A, Lisignoli G. CXCL12 chemokine upregulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients. J Cell Physiol 2004;199:244-251.
22. Lisignoli G, Cristino S, Piacentini A, Toneguzzi S, Grassi F, Cavallo C, Zini N, Solimando L, Maraldi NM, Facchini A. Cellular and molecular events during chondrogenesis of human mesenchymal stromal cells grown in a three-dimensional hya- luronan based scaffold. Biomaterials 2005;26:5677-5686.
23. Wysoczynski M, Reca R, Ratajczak J, Kucia M, Shirvaikar N, Honczarenko M, Mills M, Wanzeck J, Janowska-Wieczorek A, Ratajczak MZ. Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of haematopoietic stem/progenitor cells to an SDF-1 gradient. Blood 2005;105: 40-48.
24. Wynn RF, Hart CA, Corradi-Perini C, O'Neill L, Evans CA, Wraith JE, Fairbairn LJ, Bellantuono I. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 2004;104:2643-2645.
25. Carlsen HS, Baekkevold ES, Morton HC, Haraldsen G, Brandtzaeg P. Monocyte-like and mature macrophages produce CXCL13 (B cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis. Blood 2004;104:3021-3027.
26. Casamayor-Palleja M, Mondiere P, Amara A, Bella C, eu-Nos- jean MC, Caux C, Defrance T. Expression of macrophage inflammatory protein-3alpha, stromal cell-derived factor-1, and B-cell-attracting chemokine-1 identifies the tonsil crypt as an attractive site for B cells. Blood 2001;97:3992-3994.
27. Zhou S, Yates KE, Eid K, Glowacki J. Demineralized bone promotes chondrocyte or osteoblast differentiation of human marrow stromal cells cultured in collagen sponges. Cell Tissue Bank 2005;6:33-44.
28. Garcia AJ, Reyes CD. Bio-adhesive surfaces to promote osteoblast differentiation and bone formation. J Dent Res 2005;84:407-413.
29. Woodfield TB, Miot S, Martin I, van Blitterswijk CA, Riesle J. The regulation of expanded human nasal chondrocyte re-differentiation capacity by substrate composition and gas plasma surface modification. Biomaterials 2006;27:1043-1053.
30. Bierbaum S, Douglas T, Hanke T, Scharnweber D, Tippelt S, Monsees TK, Funk RH, Worch H. Collagenous matrix coatings on titanium implants modified with decorin and chon- droitin sulphate: Characterization and influence on osteoblastic cells. J Biomed Mater Res A 2006;77:551-562.
31. Kundu AK, Putnam AJ. Vitronectin and collagen I differentially regulate osteogenesis in mesenchymal stem cells. Bio- chem Biophys Res Commun 2006;347:347-357.
32. Salasznyk RM, Klees RF, Williams WA, Boskey A, Plopper GE. Focal adhesion kinase signalling pathways regulate the osteogenic differentiation of human mesenchymal stem cells. Exp Cell Res 2007;313:22-37.
33. Chastain SR, Kundu AK, Dhar S, Calvert JW, Putnam AJ. Adhesion of mesenchymal stem cells to polymer scaffolds occurs via distinct ECM ligands and controls their osteogenic differentiation. J Biomed Mater Res A 2006;78:73-85.
34. Curran JM, Chen R, Hunt JA. The guidance of human mesenchymal stem cell differentiation in vitro by controlled modifications to the cell substrate. Biomaterials 2006;27:4783-4793.
35. Lisignoli G, Piacentini A, Toneguzzi S, Grassi F, Cocchini B, Fer- ruzzi A, Gualtieri G, Facchini A. Osteoblasts and stromal cells isolated from femora in rheumatoid arthritis (RA) and osteoarthritis (OA) patients express IL-11, leukaemia inhibitory factor and oncostatin M. Clin Exp Immunol 2000;119:346-353.
36. Lisignoli G, Cristino S, Piacentini A, Cavallo C, Caplan AI, Facchini A. Hyaluronan-based polymer scaffold modulates the expression of inflammatory and degradative factors in mesenchymal stem cells: Involvement of CD44 and CD54. J Cell Physiol 2006;207:364-373.
37. Rozen S, Skaletsky HJ. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S, editors. Bioinformatics methods and protocols: Methods for molecular biology. Totowa, NJ: Humana Press; 2000. p 365-386.
38. Stephansson SN, Byers BA, Garcia AJ. Enhanced expression of the osteoblastic phenotype on substrates that modulate fi- bronectin conformation and integrin receptor binding. Biomaterials 2002;23:2527-2534.
39. Miot S, Woodfield T, Daniels AU, Suetterlin R, Peterschmitt I, Heberer M, van Blitterswijk CA, Riesle J, Martin I. Effects of scaffold composition and architecture on human nasal chondrocyte re-differentiation and cartilaginous matrix deposition. Biomaterials 2005;26:2479-2489.
40. Grassi F, Piacentini A, Cristino S, Toneguzzi S, Cavallo C, Facchini A, Lisignoli G. Human osteoclasts express different CXC chemokines depending on cell culture substrate: Molecular and immunocytochemical evidence of high levels of CXCL10 and CXCL12. Histochem Cell Biol 2003;120:391- 400.
41. Calvert JW, Marra KG, Cook L, Kumta PN, DiMilla PA, Weiss LE. Characterization of osteoblast-like behaviour of cultured bone marrow stromal cells on various polymer surfaces. J Biomed Mater Res 2000;52:279-284.
42. Mahmood TA, de JR, Riesle J, Langer R, van Blitterswijk CA. Adhesion-mediated signal transduction in human articular chondrocytes: The influence of biomaterial chemistry and tenascin-C. Exp Cell Res 2004;301:179-188.
43. Siebers MC, ter Brugge PJ, Walboomers XF, Jansen JA. Integ- rins as linker proteins between osteoblasts and bone replacing materials. A critical review. Biomaterials 2005;26:137-146.
44. Jono S, Peinado C, Giachelli CM. Phosphorylation of osteo- pontin is required for inhibition of vascular smooth muscle cell calcification. J Biol Chem 2000;275:20197-20203.
45. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS. Osteopontin as a means to cope with environmental insults: Regulation of inflammation, tissue remodelling, and cell survival. J Clin Invest 2001;107:1055-1061.
46. Gravallese EM. Osteopontin: A bridge between bone and the immune system. J Clin Invest 2003;112:147-149.
47. Nilsson SK, Johnston HM, Whitty GA, Williams B, Webb RJ, Denhardt DT, Bertoncello I, Bendall LJ, Simmons PJ, Haylock DN. Osteopontin, a key component of the haematopoietic stem cell niche and regulator of primitive haematopoietic progenitor cells. Blood 2005;106:1232-1239.
48. Colla S, Morandi F, Lazzaretti M, Rizzato R, Lunghi P, Bono- mini S, Mancini C, Pedrazzoni M, Crugnola M, Rizzoli V, Giuliani N. Human myeloma cells express the bone regulating gene Runx2/Cbfal and produce osteopontin that is involved in angiogenesis in multiple myeloma patients. Leukemia 2005;19:2166-2176.
49. Taichman RS, Emerson SG. The role of osteoblasts in the haematopoietic microenvironment. Stem Cells 1998;16:7-15.
50. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, Martin RP, Schipani E, Divieti P, Bringhurst FR, Milner LA, Kronenberg HM, Scadden DT. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003;425: 341-846.